Evidence mapPaperPMID 40840700Full record

ReviewJournal of lipid research2025

Multiple facets of HDLs as modifiable risk factors in stroke-the good, the bad, and the ugly.

Soumya Krishnamoorthy, S Manjunatha, Deepa Damayanthi, P N Sylaja, Srinivas Gopala

Abstract readReview
In one paragraph

Review in Journal of lipid research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Soumya KrishnamoorthyComprehensive Stroke Care Program, Department of Neurology, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Thiruvananthapuram, Kerala, India.
S ManjunathaDr B C Roy Multi Speciality Medical Research Centre, Indian Institute of Technology, Kharagpur, India. Electronic address: manjunatha.s@bcrmrc.iitkgp.ac.in.
Deepa DamayanthiDepartment of Biochemistry, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Thiruvananthapuram, Kerala, India.
P N SylajaComprehensive Stroke Care Program, Department of Neurology, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Thiruvananthapuram, Kerala, India.
Srinivas GopalaDepartment of Biochemistry, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Thiruvananthapuram, Kerala, India. Electronic address: srinivasg@sctimst.ac.in.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

HDL as a component of the lipid profile has been extensively studied for its link to CVDs, particularly its relationship with atherogenesis. It has been observed that plasma levels of HDL-C display an inverse relationship with stroke as well, suggesting that higher levels could potentially reduce the risk of stroke. Nevertheless, recent studies suggest that HDL-C alone may not fully predict stroke risk. The complexity of HDL particles arises from their diverse nature, showing significant heterogeneity in various dimensions. The functional quality of HDL extends beyond its quantity, with factors like lipoprotein subspecies (varying in size, lipid compositions, microRNA, and protein content) influencing HDL functionality under different pathophysiological conditions. This heterogeneity of HDL, particularly in the context of stroke, has received limited attention in reviews. While some studies have suggested that higher levels of HDL-C are linked to a reduced risk of stroke, others have found no such association. While HDL is known for its atheroprotective effects, its antioxidant and anti-inflammatory properties may be as vital as cholesterol efflux in preventing atherosclerosis-related stroke. This review emphasizes the importance of exploring various functionalities of HDL in the context of stroke.By elucidating the multifaceted relationship between HDL and stroke as demonstrated by contemporary literature, we aim to enhance the understanding of HDL's influence on stroke pathophysiology and identify avenues for future research in this field.

Indexed as

Cholesterol, HDLLipoproteins, HDLStrokeAnimalsHumansRisk FactorsCholesterol, HDLLipoproteins, HDLatherosclerosischolesterol effluxHDLHDL functionalityHDL particle concentrationstroke

Identifiers

PMID40840700
PMCPMC12475846

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.